CHEN, ANN,陈安,陳安,HUA, KUO FENG,花国锋,花國鋒,KA, SHUK MAN,贾淑敏,賈淑敏,CHAO, KUO PING,赵国评,趙國評,CHANG, WEN LIANG,张温良,張溫良,HWA, KUO YUAN,华国媛,華國媛
申请号：
TW102113187
公开号：
TW201438710A
申请日:
2013.04.12
申请国别(地区):
TW
年份:
2014
代理人:
摘要：
The present invention relates to use of citral for manufacturing a medicament for treating focal segmental glomerulosclerosis (FSGS). Particularly, the present invention discloses that citral is effective in alleviating symptoms of FSGS, including proteinuria, fibrosis of kidney tissue, and podocyte damage etc.本發明係關於檸檬醛用於製備治療局部腎絲球硬化症之藥物的用途。具體而言，本發明係揭露檸檬醛可有效減緩局部腎絲球硬化症之各種病徵，包括蛋白尿、腎組織纖維化及足突細胞細胞損傷等。
